Investigational Site Number 1095 — Chapel Hill, North Carolina

Investigational Site Number 1095 is a clinical research site located in Chapel Hill, North Carolina, United States 27599.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Investigational Site Number 1095 has participated in 1 clinical trials.

Therapeutic areas: Relapsing Remitting Multiple Sclerosis.

Sponsors: Genzyme, a Sanofi Company.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Chapel Hill

Browse all research sites in North Carolina · View every site in Chapel Hill

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Investigational Site Number 1095?

Investigational Site Number 1095 has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Investigational Site Number 1095 conducted?

Investigational Site Number 1095 has 1 clinical trials on record. Their work covers Relapsing Remitting Multiple Sclerosis.

Is Investigational Site Number 1095 accredited by Crixeo Clinical Trials?

Investigational Site Number 1095 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Investigational Site Number 1095?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.